Axsome 治療公司
US ˙ NasdaqGM ˙ US05464T1043

SecurityAXSM / Axsome Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Barclays Plc ownership in AXSM / Axsome Therapeutics, Inc.

On May 15, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 0 shares of Axsome Therapeutics, Inc. (US:AXSM) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 76,853 shares of Axsome Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (AXSM) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AXSM / Axsome Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -76,853 -100.00 0 -100.00
2026-02-13 2025-12-31 13F AXSOME THERAPEUTICS COM 05464T104 76,853 4,786 6.64 14,036 60.37 0.0034
2026-03-31 2025-09-30 13F/A-3 AXSOME THERAPEUTICS COM 05464T104 72,067 -25,423 -26.08 8,753 -13.99 0.0019
2026-03-19 2025-09-30 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 61,785 -35,705 5,553 0.0015
2025-11-12 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 72,067 -25,423 8,753 0.0019
2026-02-27 2025-06-30 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 97,490 45,620 87.95 10,177 68.23 0.0023
2025-08-14 2025-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 97,490 45,620 10 0.0023
2025-08-13 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 97,490 45,620 10 0.0008
2026-03-17 2025-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 51,870 -46,118 -47.06 6,050 -27.03 0.0017
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM 05464T104 51,870 -46,118 6 0.0017
2026-03-19 2024-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 97,988 36,203 58.60 8,291 49.32 0.0023
2025-02-13 2024-12-31 13F AXSOME THERAPEUTICS COM 05464T104 97,988 36,203 8 0.0023
2026-03-31 2024-09-30 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 61,785 45,509 279.61 5,553 323.82 0.0015
2024-11-19 2024-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 61,785 45,509 6 0.0015
2024-11-15 2024-09-30 13F AXSOME THERAPEUTICS COM 05464T104 61,785 45,509 6 0.0004
2026-03-23 2024-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 16,276 -203,822 -92.61 1,310 -92.54 0.0004
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM 05464T104 16,276 -203,822 1 0.0004
2026-03-24 2024-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 220,098 28,236 14.72 17,564 15.02 0.0061
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM 05464T104 220,098 28,236 18 0.0061
2026-03-25 2023-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 191,862 175,052 1,041.36 15,270 1,200.68 0.0056
2024-02-15 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 191,862 175,052 15 0.0056
2026-03-26 2023-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 16,810 16,737 22,927.40 1,175 23,380.00 0.0007
2023-11-07 2023-09-30 13F AXSOME THERAPEUTICS COM 05464T104 16,810 16,737 1 0.0007
2026-03-30 2023-06-30 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 73 73 5 0.0000
2023-09-20 2023-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 73 73 0 0.0000
2023-08-03 2023-06-30 13F AXSOME THERAPEUTICS COM 05464T104 73 73 0 0.0000
2026-03-30 2022-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 0 -26,572 -100.00 0 -100.00
2023-02-13 2022-12-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -26,572 0
2022-11-03 2022-09-30 13F AXSOME THERAPEUTICS COM 05464T104 26,572 26,572 1,186 0.0013
2022-02-23 2021-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 0 -1,571 -100.00 0 -100.00
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -1,571 0
2021-11-09 2021-09-30 13F AXSOME THERAPEUTICS COM 05464T104 1,571 -52,146 -97.08 52 -98.57 0.0000
2021-08-13 2021-06-30 13F AXSOME THERAPEUTICS COM 05464T104 53,717 18,681 53.32 3,624 82.66 0.0017
2021-05-13 2021-03-31 13F AXSOME THERAPEUTICS COM 05464T104 35,036 23,604 206.47 1,984 113.10 0.0011
2021-02-11 2020-12-31 13F AXSOME THERAPEUTICS COM 05464T104 11,432 0 0.00 931 14.23 0.0005
2020-11-12 2020-09-30 13F AXSOME THERAPEUTICS COM 05464T104 11,432 -6,361 -35.75 815 -44.33 0.0005
2020-08-12 2020-06-30 13F AXSOME THERAPEUTICS COM 05464T104 17,793 -16,678 -48.38 1,464 -27.78 0.0011
2020-05-13 2020-03-31 13F AXSOME THERAPEUTICS COM 05464T104 34,471 -30,967 -47.32 2,027 -70.03 0.0016
2020-02-10 2019-12-31 13F AXSOME THERAPEUTICS COM 05464T104 65,438 55,438 554.38 6,764 3,248.51 0.0038
2019-11-15 2019-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 10,000 -35,660 -78.10 202 -82.82 0.0001
2019-11-14 2019-09-30 13F AXSOME THERAPEUTICS COM 05464T104 10,000 -35,660 202 46.7026
2019-08-14 2019-06-30 13F AXSOME THERAPEUTICS COM 05464T104 45,660 45,485 25,991.43 1,176 58,700.00 0.0007
2019-05-15 2019-03-31 13F AXSOME THERAPEUTICS COM 05464T104 175 -10,325 -98.33 2 -93.33 0.0000
2019-02-14 2018-12-31 13F AXSOME THERAPEUTICS COM 05464T104 10,500 10,500 5,900.00 30 1,400.00 0.0000
2018-11-14 2018-09-30 13F AXSOME THERAPEUTICS COM 05464T104 0 -36,500 -100.00 0 -100.00
2018-08-14 2018-06-30 13F AXSOME THERAPEUTICS COM 05464T104 36,500 900 2.53 117 34.48 0.0001
2018-05-15 2018-03-31 13F AXSOME THERAPEUTICS COM 05464T104 35,600 35,600 -2.47 87 -25.64 0.0001
2018-02-14 2017-12-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -17,500 -100.00 0 -100.00
2017-11-14 2017-09-30 13F AXSOME THERAPEUTICS COM 05464T104 17,500 1,310 8.09 97 8.99 0.0001
2017-08-14 2017-06-30 13F AXSOME THERAPEUTICS COM 05464T104 16,190 8,333 106.06 89 196.67 0.0001
2017-05-15 2017-03-31 13F AXSOME THERAPEUTICS COM 05464T104 7,857 7,718 5,552.52 30 2,900.00 0.0000
2017-02-14 2016-12-31 13F AXSOME THERAPEUTICS COM 05464T104 139 0 0.00 1 0.00 0.0000
2016-11-14 2016-09-30 13F AXSOME THERAPEUTICS COM 05464T104 139 139 1 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-03-23 2024-06-30 13F/A AXSOME THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS OPT Call 0 0 n/a n/a n/a
2026-03-24 2024-03-31 13F/A AXSOME THERAPEUTICS OPT Call 27,500 -47.12 2,194 -46.98 n/a n/a n/a
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS OPT Call 27,500 2 n/a n/a n/a
2026-03-25 2023-12-31 13F/A AXSOME THERAPEUTICS OPT Call 52,000 4,139 n/a n/a n/a
2024-02-15 2023-12-31 13F AXSOME THERAPEUTICS OPT Call 52,000 4 n/a n/a n/a
2020-08-12 2020-06-30 13F AXSOME THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F AXSOME THERAPEUTICS OPT Call 201,500 210.48 11,854 76.71 n/a n/a n/a
2020-02-10 2019-12-31 13F AXSOME THERAPEUTICS OPT Call 64,900 226.13 6,708 1,564.52 n/a n/a n/a
2019-11-15 2019-09-30 13F/A AXSOME THERAPEUTICS OPT Call 19,900 -66.44 403 -73.61 n/a n/a n/a
2019-11-14 2019-09-30 13F AXSOME THERAPEUTICS OPT Call 19,900 403 n/a n/a n/a
2019-08-14 2019-06-30 13F AXSOME THERAPEUTICS OPT Call 59,300 -38.93 1,527 10.49 n/a n/a n/a
2019-05-15 2019-03-31 13F AXSOME THERAPEUTICS OPT Call 97,100 1,382 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-03-23 2024-06-30 13F/A AXSOME THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS OPT Put 0 0 n/a n/a n/a
2026-03-24 2024-03-31 13F/A AXSOME THERAPEUTICS OPT Put 27,500 -47.12 2,194 -46.98 n/a n/a n/a
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS OPT Put 27,500 2 n/a n/a n/a
2026-03-25 2023-12-31 13F/A AXSOME THERAPEUTICS OPT Put 52,000 4,139 n/a n/a n/a
2024-02-15 2023-12-31 13F AXSOME THERAPEUTICS OPT Put 52,000 4 n/a n/a n/a
2022-02-23 2021-12-31 13F/A AXSOME THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS OPT Put 0 0 n/a n/a n/a
2021-11-09 2021-09-30 13F AXSOME THERAPEUTICS OPT Put 58,800 17.60 1,938 -42.54 n/a n/a n/a
2021-08-13 2021-06-30 13F AXSOME THERAPEUTICS OPT Put 50,000 3,373 n/a n/a n/a
2020-08-12 2020-06-30 13F AXSOME THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F AXSOME THERAPEUTICS OPT Put 5,000 -83.33 294 -90.52 n/a n/a n/a
2020-02-10 2019-12-31 13F AXSOME THERAPEUTICS OPT Put 30,000 500.00 3,101 954.76 n/a n/a n/a
2019-11-15 2019-09-30 13F/A AXSOME THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F AXSOME THERAPEUTICS OPT Put 2,900 -96.62 75 -93.85 n/a n/a n/a
2019-05-15 2019-03-31 13F AXSOME THERAPEUTICS OPT Put 85,700 1,220 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.